Clonal restriction of T-cell receptor expression by infiltrating lymphocytes in inclusion body myositis persists over time. Studies in repeated muscle biopsies.

Inclusion body myositis (IBM) is an inflammatory myopathy characterized immunohistologically by prominent invasion of the non-necrotic, MHC-I class antigen-expressing muscle fibres by CD8+ cytotoxic T cells. If the autoinvasive CD8+ T cells are recruited specifically to the muscle and play a primary pathogenetic role in the disease, a clonal restriction persisting over time should be anticipated. In this study, we analysed the T-cell receptor (TCR) gene usage by endomysial T lymphocytes in three sequential muscle biopsies from three different IBM patients over a 19-22 month period using immunohistochemistry, reverse transcription-polymerase chain reaction (RT-PCR) and sequence analysis of the complementarity determining region (CDR3) of the amplified TCRs. We found that CD8+ T lymphocytes persist in the endomysial infiltrates in all biopsies during a 19-22 month period. The most frequently detected TCRs were the V beta 3, V beta 5.1, V beta 6.7 and V beta 13 gene families, and several of the autoinvasive CD8+ T cells expressed the TCRs V beta 6.7 and V beta 5.1. A restricted usage of the examined V beta 6 gene family was found to persist in the complementarity CDR3 determining region of the autoinvasive T cells over the 22 month period. Identical V beta 6 CDR3 gene arrangements were also found in the multiple muscle biopsies from two of the three IBM patients. The results indicate that in IBM there is a restricted expression of the TCR gene families among the autoinvasive T lymphocytes with homologies in the CDR3 region that persist over the course of the disease. A continuous, antigen-driven T-cell response is prominent in the muscle of patients with IBM.

[1]  A. Tarkowski,et al.  Restricted use of T cell receptor V genes in endomysial infiltrates of patients with inflammatory myopathies , 1994, European journal of immunology.

[2]  R. Hohlfeld,et al.  Human muscle cells express a functional costimulatory molecule distinct from B7.1 (CD80) and B7.2 (CD86) in vitro and in inflammatory lesions. , 1998, Journal of immunology.

[3]  J. Mendell,et al.  Inclusion body myositis , 1995, Neurology.

[4]  T. Sumida,et al.  Restricted junctional usage of T cell receptor V beta 2 and V beta 13 genes, which are overrepresented on infiltrating T cells in the lips of patients with Sjögren's syndrome. , 1992, Arthritis and rheumatism.

[5]  M. Dalakas,et al.  Polymyositis inpatients infected with human T‐cell leukemia virus type I: The role of the virus in the cause of the disease , 1994, Annals of neurology.

[6]  D. Carlo,et al.  Limited T-cell receptor beta-chain heterogeneity among interleukin 2 receptor-positive synovial T cells suggests a role for superantigen in rheumatoid arthritis. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[7]  Andrew G. Engel,et al.  αB-Crystallin immunolocalization yields new insights into inclusion body myositis , 2000, Neurology.

[8]  A. Engel,et al.  Analysis of cytokine expression in muscle in inflammatory myopathies, Duchenne dystrophy, and non-weak controls , 1995, Journal of Neuroimmunology.

[9]  H. Goebel,et al.  Cytokine Expression Profile in Idiopathic Inflammatory Myopathies , 1996, Journal of neuropathology and experimental neurology.

[10]  M. Dalakas,et al.  Molecular immunology and genetics of inflammatory muscle diseases. , 1998, Archives of neurology.

[11]  M. Dalakas Polymyositis, dermatomyositis and inclusion-body myositis. , 1991, The New England journal of medicine.

[12]  M. Dalakas,et al.  Immune‐mediated conditions and antibodies associated with sporadic inclusion body myositis , 1998, Muscle & nerve.

[13]  E. Heber-Katz,et al.  The V-region disease hypothesis: evidence from autoimmune encephalomyelitis. , 1989, Immunology today.

[14]  H. Goebel,et al.  Expression of cell adhesion molecules in inflammatory myopathies , 1995, Journal of Neuroimmunology.

[15]  Jingwu Z. Zhang,et al.  Clonal expansion of myelin basic protein‐reactive T cells in patients with multiple sclerosis: Restricted T cell receptor V gene rearrangements and CDR3 sequence , 1995, European journal of immunology.

[16]  A. Begovich,et al.  Selection for T-cell receptor Vβ–Dβ–Jβ gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis , 1993, Nature.

[17]  M. Dalakas,et al.  HLA allele distribution distinguishes sporadic inclusion body myositis from hereditary inclusion body myopathies , 1998, Journal of Neuroimmunology.

[18]  A. Engel,et al.  Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells , 1984, Annals of neurology.

[19]  A. Engel,et al.  Monoclonal antibody analysis of mononuclear cells in myopathies. II: Phenotypes of autoinvasive cells in polymyositis and inclusion body myositis , 1984, Annals of neurology.

[20]  R. Cattaneo,et al.  Restricted expression of T cell receptor Vβ but not Vα genes in rheumatoid arthritis , 1991 .

[21]  F. Breedveld,et al.  T-cell receptor V-gene usage in synovial fluid lymphocytes of patients with chronic arthritis. , 1993, Human immunology.

[22]  L. Steinman,et al.  Analysis of the T cell repertoire using the PCR and specific oligonucleotide primers. , 1992, BioTechniques.

[23]  P. Gregersen,et al.  Oligoclonality of V beta 3 TCR chains in the CD8+ T cell population of rheumatoid arthritis patients. , 1996, Journal of immunology.

[24]  M. Dalakas,et al.  Expression of the costimulatory molecule BB-1, the ligands CTLA-4 and CD28, and their mRNA in inflammatory myopathies. , 1999, The American journal of pathology.

[25]  D. Hafler,et al.  Clonal expansion and persistence of human T cells specific for an immunodominant myelin basic protein peptide. , 1994, Journal of immunology.

[26]  M. Dalakas,et al.  The αβ T-Cell Receptor Repertoire in Inclusion Body Myositis: Diverse Patterns of Gene Expression by Muscle-infiltrating Lymphocytes , 1994 .

[27]  Marinos C. Dalakas Immunopathogenesis of inflammatory myopathies , 1995, Annals of neurology.

[28]  Christopher Lindberg,et al.  Oligoclonal expansion of muscle infiltrating T cells in inclusion body myositis , 1997, Journal of Neuroimmunology.

[29]  Reinhard Hohlfeld,et al.  T-cell heterogeneity in muscle lesions of inclusion body myositis , 1998, Journal of Neuroimmunology.

[30]  A. Oldfors,et al.  Limited T‐Cell Receptor V Gene Usage in Inclusion Body Myositis , 1996, Scandinavian journal of immunology.

[31]  D. Hafler,et al.  TCR usage in human and experimental demyelinating disease. , 1996, Immunology today.

[32]  A. Engel,et al.  Expression of Cell Adhesion Molecules in Inflammatory Myopathies and Duchenne Dystrophy , 1994, Journal of neuropathology and experimental neurology.